CK Regeon Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects (NCT05833906) | CK Regeon Inc. | 2023-04-25 |
Track CK Regeon Inc. automatically
Every clearance here is in the API, with alerts when new ones post.